WASHINGTON — Vietnam War veterans exposed to Agent Orange have a higher risk of developing a rare blood cancer that develops slowly over decades, according to a new study that for the first time links ...

Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...

“This study has been a personal quest,” said Mikkael Sekeres, M.D., chief of hematology at Sylvester Comprehensive Cancer Center. “I see veterans who develop these conditions and need expensive ...

ECOG performance status, IPSS risk scores, bone marrow blast percentage, TP53 mutations, and cytogenetic abnormalities independently predicted prognosis. Complete remission significantly improved ...

Complications from myelodysplastic syndromes (MDS), like anemia or fatigue, can occur because the bone marrow isn’t making enough healthy or functional blood cells. Myelodysplastic syndromes (MDS) are ...

Malaysian state energy firm Petronas said on Wednesday that it remains committed to meeting its contractual obligations and maintaining reliable gas supply for buyers following a Court of Appeal ...

Myelodysplastic syndromes (MDS) and autoimmune conditions appear to have a two-way connection. Living with one may increase your risk of developing the other. Myelodysplastic syndromes (MDS) are a ...

Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases ...

OpenAI was the company that signed a $30 billion per year deal with Oracle for data center services, disclosed last month, The Wall Street Journal reported on Monday. Now, OpenAI CEO Sam Altman has ...

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...

Microsoft today announced an artificial intelligence tool that outperformed a panel of medical doctors in diagnosing complicated cases. The Microsoft AI Diagnostic Orchestrator (MAI-DxO) faced off ...